Assenagon Asset Management S.A. Has $683,000 Position in Inogen, Inc. (NASDAQ:INGN)

Assenagon Asset Management S.A. decreased its holdings in shares of Inogen, Inc. (NASDAQ:INGN) by 68.3% in the 4th quarter, HoldingsChannel reports. The firm owned 74,452 shares of the medical technology company’s stock after selling 160,429 shares during the period. Assenagon Asset Management S.A.’s holdings in Inogen were worth $683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in INGN. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Inogen by 312.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after buying an additional 132,287 shares during the last quarter. AQR Capital Management LLC raised its holdings in Inogen by 29.3% in the 2nd quarter. AQR Capital Management LLC now owns 570,994 shares of the medical technology company’s stock valued at $4,642,000 after acquiring an additional 129,307 shares during the period. Sanctuary Advisors LLC acquired a new stake in Inogen during the second quarter worth approximately $651,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Inogen during the second quarter worth approximately $457,000. Finally, Royce & Associates LP grew its position in shares of Inogen by 167.4% in the third quarter. Royce & Associates LP now owns 51,891 shares of the medical technology company’s stock valued at $503,000 after purchasing an additional 32,482 shares during the last quarter. 89.94% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on INGN. StockNews.com cut Inogen from a “buy” rating to a “hold” rating in a report on Friday, December 20th. Needham & Company LLC reissued a “hold” rating on shares of Inogen in a report on Tuesday, January 14th.

Inogen Stock Up 3.2 %

Shares of NASDAQ:INGN opened at $11.44 on Friday. Inogen, Inc. has a 12-month low of $5.37 and a 12-month high of $13.33. The company’s 50 day moving average price is $9.59 and its two-hundred day moving average price is $10.02. The firm has a market cap of $272.48 million, a PE ratio of -5.08 and a beta of 1.02.

Inogen (NASDAQ:INGN) last posted its quarterly earnings data on Thursday, November 7th. The medical technology company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.26. The firm had revenue of $88.83 million for the quarter, compared to analyst estimates of $83.68 million. Inogen had a negative return on equity of 27.38% and a negative net margin of 15.89%. During the same quarter last year, the company earned ($1.97) EPS. On average, research analysts expect that Inogen, Inc. will post -1.73 EPS for the current year.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.